CorMedix Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:CRMD) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 149.58 M252.6 M750.86 M826.14 M815.64 M Total liabilities 34.69 M31.97 M376.73 M420.83 M378.59 M Total equity 114.89 M220.63 M374.13 M405.31 M437.05 M Total liabilities & shareholders' equities 149.58 M252.6 M750.86 M826.14 M815.64 M Total debt ——295.11 M890.63 K— Net debt ——239.39 M-147.64 M—

News

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates

Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue?

CRMD's Growth Story Expands Beyond DefenCath Into New Trends

Is CRMD Stock a Buy Now After Strong Growth and New Risks?

CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path

CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised

CorMedix Inc. (CRMD) Q1 2026 Earnings Call Transcript

CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue Estimates

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates

CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release